Authors:
Patel, U
Yan, YP
Hobbs, FW
Kaczmarczyk, J
Slee, AM
Pompliano, DL
Kurilla, MG
Bobkova, EV
Citation: U. Patel et al., Oxazolidinones mechanism of action: Inhibition of the first peptide bond formation, J BIOL CHEM, 276(40), 2001, pp. 37199-37205
Authors:
Steigerwald-Mullen, P
Kurilla, MG
Braciale, TJ
Citation: P. Steigerwald-mullen et al., Type 2 cytokines predominate in the human CD4+T-lymphocyte response to Epstein-Barr virus nuclear antigen 1, J VIROLOGY, 74(15), 2000, pp. 6748-6759
Authors:
Jin, X
Demoitie, MA
Donahoe, SM
Ogg, GS
Bonhoeffer, S
Kakimoto, WM
Gillespie, G
Moss, PA
Dyer, W
Kurilla, MG
Riddell, SR
Downie, J
Sullivan, JS
McMichael, AJ
Workman, C
Nixon, DF
Citation: X. Jin et al., High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A0201-positive subjects during multiple viral coinfections, J INFEC DIS, 181(1), 2000, pp. 165-175
Authors:
Munz, C
Bickham, KL
Subklewe, M
Tsang, ML
Chahroudi, A
Kurilla, MG
Zhang, D
O'Donnell, M
Steinman, RM
Citation: C. Munz et al., Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barrvirus nuclear antigen EBNA1, J EXP MED, 191(10), 2000, pp. 1649-1660
Authors:
Subklewe, M
Chahroudi, A
Bickharn, K
Larsson, M
Kurilla, MG
Bhardwaj, N
Steinman, RM
Citation: M. Subklewe et al., Presentation of Epstein-Barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytes, EUR J IMMUN, 29(12), 1999, pp. 3995-4001
Authors:
Subklewe, M
Chahroudi, A
Schmaljohn, A
Kurilla, MG
Bhardwaj, N
Steinman, RM
Citation: M. Subklewe et al., Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus, BLOOD, 94(4), 1999, pp. 1372-1381